Remus PharmaceuticalsNSE:REMUS +2.86%54 Dividend Payout Ratio is 0.02 as of Mar. 2026, which is 33% below its 10-year median of 0.03. GuruFocus rates NSE:REMUS with a GF Score™ of 54/100 and a GF Value™ of ₹2,071.36 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 61 Medical Distribution companies, Remus Pharmaceuticals ranks better than 96.72% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Remus Pharmaceuticals's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.02.
The historical rank and industry rank for Remus Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:
NSE:REMUS'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.02 Med: 0.03 Max: 0.03
Current: 0.03
During the past 7 years, the highest Dividend Payout Ratio of Remus Pharmaceuticals was 0.03. The lowest was 0.02. And the median was 0.03.
NSE:REMUS's Dividend Payout Ratio is ranked better than 96.72% of 61
companies
in the Medical Distribution industry
Industry Median: 0.43
vs NSE:REMUS: 0.03
During the past 7 years, the highest Trailing Annual Dividend Yield of Remus Pharmaceuticals was 0.16%. The lowest was 0.04%. And the median was 0.10%.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Remus Pharmaceuticals (NSE:REMUS) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Remus Pharmaceuticals Dividend Payout Ratio Related Terms
Remus Pharmaceuticals Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Remus Pharmaceuticals's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:REMUS vs MCK, CAH, COR: Dividend Payout Ratio Comparison
For the Medical Distribution subindustry, Remus Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Remus Pharmaceuticals Dividend Payout Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Remus Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Remus Pharmaceuticals's Dividend Payout Ratio falls into.
Remus Pharmaceuticals Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Remus Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Remus Pharmaceuticals (NSE:REMUS) has a Dividend Payout Ratio of 0.02 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Remus Pharmaceuticals and its competitors. This is 33% below median its historical median of 0.03. Over the past decade, Remus Pharmaceuticals' Dividend Payout Ratio has ranged from 0.02 to 0.03. According to the industry distribution chart, Remus Pharmaceuticals ranks #2 out of 61 companies in the Medical Distribution industry, placing it in the top 3.3%.
Is Remus Pharmaceuticals' Dividend Payout Ratio too high?
Remus Pharmaceuticals' current Dividend Payout Ratio of 0.02 is 33% below median its 10-year median of 0.03. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 0.03. The Medical Distribution industry median Dividend Payout Ratio is 0.43. Remus Pharmaceuticals' value of 0.02 is 95.3% below this industry median. Based on the distribution chart, Remus Pharmaceuticals ranks #2 out of 61 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Remus Pharmaceuticals has a GF Score™ of 54/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Remus Pharmaceuticals' Dividend Payout Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Remus Pharmaceuticals ranks #2 out of 61 companies for Dividend Payout Ratio. This places Remus Pharmaceuticals in the top 3% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.43. Remus Pharmaceuticals' value of 0.02 is 95.3% below this benchmark. Historically, Remus Pharmaceuticals' own Dividend Payout Ratio has ranged from 0.02 to 0.03 over the past decade. While the company's 10-year median is 0.03 vs. the industry median of 0.43, Remus Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Distribution company?
The median Dividend Payout Ratio among Medical Distribution companies is 0.43, based on 61 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Remus Pharmaceuticals's current Dividend Payout Ratio of 0.02 is 95.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Remus Pharmaceuticals and its competitors. For the Medical Distribution industry, the median Dividend Payout Ratio is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Remus Pharmaceuticals's current Dividend Payout Ratio is 0.02, which is 33% below median its own 10-year median of 0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Remus Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Remus Pharmaceuticals (NSE:REMUS) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹2,071.36, compared to a current price of ₹767.40 — trading 63% below its estimated fair value. The current Dividend Payout Ratio is 0.02, which is 33% below median its 10-year median of 0.03 and 95.3% below the Medical Distribution industry median of 0.43. Remus Pharmaceuticals' overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Remus Pharmaceuticals (NSE:REMUS), the current Dividend Payout Ratio is 0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Remus Pharmaceuticals (NSE:REMUS) Overvalued in 2026?
Based on GuruFocus' analysis, Remus Pharmaceuticals stock appears to be undervalued.
The current stock price of ₹767.40 is trading 63% below its estimated GF Value™ of ₹2,071.36.
GuruFocus considers Remus Pharmaceuticals to be Significantly Undervalued.
Key valuation signals for NSE:REMUS:
Dividend Payout Ratio: 0.02 (33% below median its 10-year median of 0.03)
GF Value™: ₹2,071.36 vs. price of ₹767.40 (63% below fair value)
Industry Position: 95.3% below the Medical Distribution median (#2 of 61)
No single metric tells the full story. See the NSE:REMUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.
54GF Score
Get the complete analysis for NSE:REMUS
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:REMUS has been successfully added to your 
